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Abstract
Understanding more about the host’s immune response to different Cryptococcus spp. will provide additional insight into
the pathogenesis of cryptocococcis. We hypothesized that the ability of C. gattii to cause disease in immunocompetent
humans depends on a distinct innate cytokine response of the host to this emerging pathogen. In the current study we
assessed the cytokine profile of human peripheral blood mononuclear cells (PBMCs) of healthy individuals, after in vitro
stimulation with 40 different well-defined heat-killed isolates of C. gattii, C. neoformans and several hybrid strains. In
addition, we investigated the involvement of TLR2, TLR4 and TLR9 in the pro-inflammatory cytokine response to C. gattii.
Isolates of C. gattii induced higher concentrations of the pro-inflammatory cytokines IL-1b, TNF-a and IL-6 and the Th17/22
cytokine IL-17 and IL-22 compared to C. neoformans var neoformans and C. neoformans var grubii. In addition, clinical C.
gattii isolates induced higher amounts of cytokines than environmental isolates. This difference was not observed in C.
neoformans var. grubii isolates. Furthermore, we demonstrated a likely contribution of TLR4 and TLR9, but no role for TLR2,
in the host’s cytokine response to C. gattii. In conclusion, clinical heat-killed C. gattii isolates induced a more pronounced
inflammatory response compared to other Cryptococcus species and non-clinical C. gattii. This is dependent on TLR4 and
TLR9 as cellular receptors.
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Introduction
The incidence of cryptococcosis has increased dramatically over
the past decades, due in a large part to the global HIV pandemic.
More than 600,000 deaths are estimated to occur each year as a
result of cryptococcal meningoencephalitis [1]. The species C.
neoformans is an opportunistic pathogen mainly affecting immuno-
compromised hosts. In contrast, C. gattii mainly causes disease in
apparently immunocompetent hosts at lower incidence [2,3]. C.
gattii is emerging over the past decade as a pathogen in the Pacific
North-West of North America and has caused a large outbreak on
Vancouver Island [4,5]. This outbreak was mainly caused by a
single, hypervirulent genotype of C. gattii, namely AFLP6A/VGIIa
[6].
Cells of the innate immune system are important for initial
defense against pathogens. Upon contact with pathogens, they
produce pro-inflammatory cytokines such as tumor necrosis factor
(TNF)-a, Interleukin (IL)-1b and IL-6, thereby initiating a specific
adaptive cellular immune response. Anti-inflammatory cytokines
such as IL-1RA are also produced and act as downregulators of
this immune response. Of particular interest for fungal infections,
the cytokines IL-1b and IL-6 in the presence of IL-23 induce the
development of T-helper (Th)17 cells. IL-17 and IL-22, the major
cytokines excreted by Th17 cells, have several pro-inflammatory
functions, one of which is eliciting defensin production by
epithelial cells [7]. Previous studies have shown a crucial role of
Th17 cells in human antifungal defense against mucosal Candida
albicans infections [8–10]; but the role of this particular Th-
lymphocyte subset in anti-cryptococcal defense is not clear.
Which cytokines are released depends on recognition of
microbial components by pattern recognition receptors (PRRs)
on the cells of the innate immune system. Toll-like receptors
(TLRs), a well-defined set of PRRs, are expressed on a variety of
cells and are important mediators of pro-inflammatory cytokine
release. However, their role in mediating cytokine response to
Cryptococcus spp. is being debated [11–15].
Understanding more about the host’s immune response to
different Cryptococcus spp, will provide additional insight into the
pathogenesis of cryptocococcis. We hypothesized that the ability of
C. gattii to cause disease in immunocompetent humans depends on
a distinct innate cytokine response of the host to this emerging
pathogen. Therefore, in the current study we assessed the cytokine
profile of human peripheral blood mononuclear cells (PBMCs) of
healthy individuals, after in vitro stimulation with well-defined heat-
killed isolates of C. gattii, C. neoformans and several hybrids. In
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addition, we investigated the involvement of TLR2, TLR4 and
TLR9 in the pro-inflammatory cytokine response to C. gattii.
Results
Quantitative comparison of cytokine induction between
different Cryptococcus spp.
We determined the concentration of several cytokines produced
by PBMCs upon stimulation with 40 different heat-killed
Cryptococcus species complex isolates in order to elucidate the
cytokine milieu in cryptococcal infection and to explore differences
between the species. In preliminary experiments, we determined
that the minimal concentration of yeasts necessary to induce
cytokine production is 107 microorganisms/mL (data not shown).
There was substantial inter-strain variation in the production of
the pro-inflammatory cytokines IL-1b, TNF-a, IL-6 and the anti-
inflammatory cytokine IL-1Ra. TNF-a and IL-1b were induced in
low amounts (up to 300 pg/mL). Interestingly, production of these
cytokines using a 100-fold lower concentration of Candida albicans
was much higher (data not shown). Results for the induction of T-
cell derived cytokines IL-17 and IL-22 after 7 days of incubation
are shown in Figure 1. It appeared that the studied Cryptococcus
strains induce low amounts of IL-17 but substantial quantities of
IL-22, again with significant inter-strain variation in the produc-
tion of these cytokines.
Figure 2 shows a quantitative comparison of cytokine induction
between two varieties of C. neoformans, C. gattii and various hybrid
isolates. C. gattii was a more potent inducer of the pro-
inflammatory cytokines TNF-a, IL-1b, IL-6 and the T-cell
cytokines IL-17 and IL-22, compared to both C. neoformans
varieties. The different species did not differ with regard to IL-
1Ra induction. Interestingly, the interspecies hybrids containing C.
gattii as a partner of the mating pair induced significantly higher
cytokine production than hybrids which were the result of mating
between the two varieties of C. neoformans. This suggests that an
Figure 1. All forty Cryptococcus strains induce low amounts of IL-17, but high amounts of IL-22. IL-17 and IL-22 production after 7 d by
PBMCs stimulated with RPMI+, either one of 40 different heat-killed Cryptococcus strains [107 microorganisms/mL] or heat-killed Candida albicans [105
microorganisms/mL] is shown respectively. Mean values 6 SE (n = 5) of three independent experiments are presented.
doi:10.1371/journal.pone.0055579.g001
Cryptococcus gattii Induced Cytokine Pattern
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inheritable factor is responsible for the difference in cytokine
production.
Quantitative comparison of cytokine induction between
environmental and clinical strains within the
Cryptococcus species complex
Sixteen clinical C. gattii isolates (isolates 10,12,14,18,19–21,23–
29,39,40), of which six isolates belonging to the genotype AFLP6/
VGII which was involved in the Vancouver Island outbreak, were
compared to four environmental C. gattii isolates (isolates
13,15,16,17), as well as to four clinical C. neoformans isolates
(isolates 1,4,5,9), with regard to the cytokine induction (Figure 3).
Clinical C. gattii isolates induced significantly higher IL-1b and IL-
6 amounts compared to environmental isolates. Moreover, clinical
C. gattii isolates also induced higher IL-1b, IL-6, TNF-a, IL-1Ra
and IL-17 than clinical C. neoformans isolates. The C. gattii genotype
Figure 2. Comparison of C. gattii isolates and interspecies hybrids with C. neoformans isolates and hybrids between both C.
neoformans varieties. The forty heat-killed Cryptococcus isolates are grouped according to (sub)species. Cytokine production by human PBMCs
after 24 h (IL-1b, TNF-a, IL-6 and IL-1Ra) and 7 d (IL-17 and IL-22) incubation is shown. Mean values (n = 5 to 7) 6 SE of three independent
experiments are presented. *, p 0.01 to 0.05; **, p 0.001 to 0.01; ***, p,0.001. The horizontal line represents the lower detection limit.
doi:10.1371/journal.pone.0055579.g002
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AFLP6/VGII, however, induced no higher amounts of other
cytokines compared to the other clinical C. gattii isolates.
In a different panel of Cuban C. neoformans var grubii isolates,
comparison of clinical with environmental isolates showed no
significant difference (P value for IL-6 and IL-22: 0.19 and 0.07
respectively) in cytokine production (Figure 4). The induction of
low levels of cytokines by C. neoformans var grubii isolates, as seen in
the panel of 40 isolates, was confirmed.
Involvement of different Pattern Recognition Receptors
(PRRs) in cytokine production induced by C. gattii
To assess which PRRs are involved in recognizing C. gattii, we
performed experiments in which PBMCs were preincubated for
Figure 3. Comparison of cytokine production by PBMCs induced by clinical or environmental cryptococcal isolates. Heat killed clinical
isolates of C. gattii are compared to environmental C. gattii isolates and to clinical isolates of C. neoformans. The clinical isolates of C. gattii genotype
AFLP6/VGII are depicted separately. Mean values (n = 5 to 7)6 SE values of three independent experiments are presented. *, p 0.01 to 0.05; **, p 0.001
to 0.01; ***, p,0.001. The horizontal line represents the lower detection limit.
doi:10.1371/journal.pone.0055579.g003
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one hour with specific PRR blocking reagents prior to stimulation
with heat-killed C. gattii or, as a control, culture medium.
Stimulation with culture medium showed undetectable levels for
all cytokines (not shown). Blocking TLR2 had no effect on
cytokine production by C. gattii, whereas this antibody significantly
inhibited IL-1beta production after stimulation with Pam3cys (a
known TLR-2 ligand) (Figure S1). Blocking TLR4 significantly
diminished IL-1b induction by C. gattii, with a trend towards
significance for TNF-a (P = 0.06). Interestingly, blocking TLR9 led
to significantly higher concentrations of IL-1b induced by C. gattii
compared to its control, and a trend towards significance (P = 0.06)
was found for TNF-a. Blocking TLR9 had a negative effect
(P = 0.03) on IL-17 production induced by C. gattii (Figure 5 for the
effect on IL-1b and IL-17).
We performed these experiments also with C. neoformans var
grubii (H99). The latter isolate did not elicit a substantial pro-
inflammatory cytokine response in PBMCs, as shown in previous
experiments with other strains. Moreover, we did not observe an
increase in IL-1b and TNF-a production induced by C. neoformans
var grubii when blocking TLR9 (results not shown).
Discussion
In the present study we investigated the in-vitro cytokine
production of human PBMCs incubated with 40 different heat-
killed isolates of the Cryptococcus neoformans species complex. We
demonstrate that C. gattii isolates induces higher concentrations of
pro-inflammatory and Th17/22 cytokines compared to C. neofor-
mans var. neoformans and C. neoformans var. grubii. In addition, we
found that clinical C. gattii isolates were able to induce higher
amounts of cytokines than environmental isolates or clinical C.
neoformans isolates. Furthermore, we demonstrated a contribution
of TLR4 and TLR9, but no role for TLR2, in the host’s cytokine
response to C. gattii.
Our results indicate that Cryptococcus neoformans species complex
seems to induce mainly a IL-22 response, with surprisingly low IL-
17 production. This argues against a Th17 response to crypto-
coccal infection as we hypothesized, but rather to an exclusively
IL-22 producing subset of Th-cells. A candidate for this areTh22
cells. These cells have not been found in mice so far; therefore only
studies with human cells can be used to determine the role of this
Th subset in host defense against cryptococcal infections. The aryl
hydrocarbon receptor is identified to mediate IL-22 production
without mediating IL-17 and seems to be critical in differentiation
of naı¨ve T cells to Th22 cells [16]. IL-22 is a unique cytokine in
that it acts only on non-immune cells including keratinocytes,
myofibroblasts and epithelial cells in tissues of the respiratory
Figure 4. Comparison of cytokine production by PBMCs induced by clinical or environmental C. neoformans var grubii isolates.
Cytokine production by human PBMCs after 24 h (IL-6) and 7 d (IL-22) incubation with heat-killed isolates is shown. Mean values (n = 7)6 SE of three
independent experiments are presented. ns, not significant.
doi:10.1371/journal.pone.0055579.g004
Figure 5. The role of TLR2, TLR4 and TLR9 in IL-1b and IL-17
induction by C. gattii. Cytokine production by human PBMCs
preincubated for one hour with culture medium (white bar) or PRR
blocking reagents (dark gray bars) or their control (light gray bar) prior
to stimulation with heat-killed C. gattii (strain B5742) [107/ml]. IL-1b is
determined after 24 h incubation, IL-17 is determined after 7 d
incubation. Mean values 6 SE of eight individuals in 4 independent
experiments (IL-17) or six individuals in 5 independent experiments (IL-
1b) (with exclusion of additional four individuals with undetectable
cytokine induction by C. gattii) are presented. *, p 0.01 to 0.05. The
horizontal line represents the lower detection limit.
doi:10.1371/journal.pone.0055579.g005
Cryptococcus gattii Induced Cytokine Pattern
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ystem, skin and digestive tract, which express receptors for this
cytokine [17]. IL-22 promotes the production of antimicrobial
agents called b-defensins by epithelial cells and serves in mucosal
defenses against pathogens. It is tempting to speculate that IL-22 is
important for the initial anti-cryptococcal defense because it has a
function at the place of entrance of this yeast, namely the epithelial
surface of the respiratory system. However, to confirm these
speculations, further research should be attempted to identify the
role of IL-22 and Th22 cells in clinical patients with cryptococ-
cosis.
Higher amounts of the pro-inflammatory cytokines IL-1b,
TNFa, IL-6, IL-17 and IL-22 by human PBMCs were induced by
C. gattii compared to both varieties of C. neoformans, indicating that
certain (virulence) factors of C. gattii are responsible for a more
pronounced inflammatory reaction. This finding is strengthened as
the same trend was seen in the hybrids containing C. gattii as a
partner of the mating pair. Therefore we suggest that an
inheritable factor is responsible for the difference in cytokine
production.
Our finding that C. gattii induces a more powerful pro-
inflammatory response aimed at more efficient defense against
the pathogen is supported by the work of Ngamskulrungroj et al
[18]. The authors compared the pathogenesis of the two
Cryptococcus species in mice using an inhalation model and they
found that in naive mice, C. gattii grew significantly slower in blood
than C. neoformans. Infection with C. gattii was restricted to the
lungs, while C. neoformans dissimenated to the brain causing
meningoencephalitis. When mice were infected intravenously with
low inoculums of yeast, C. neoformans was more virulent than C.
gattii. Apparently, in this murine model the host’s peripheral
immune cells are able to clear C. gattii infection more efficiently,
probably by a more adequate cytokine response. However, in
humans, C. gattii species seem to be more virulent, as they are able
to cause disease in apparently immunocompetent hosts. Large-
scale environmental colonization for C. gattii was found during the
Vancouver Island outbreak, whereas only relatively few people
developed overt disease [6]. It can be hypothesized that a specific
defect in the innate immune system of affected hosts predisposes
them to infection with C. gattii. Furthermore, other factors such as
intracellular survival, outgrowth or dissemination may also be
important for virulence of C. gattii, independent of the initial pro-
inflammatory cytokine response [19]. In our experiments we used
PBMCs of healthy individuals who are expected to have an
adequate immune response to C. gattii. These cells reflect the
second line of defense when the yeast enters the host after
inhalation. Our results showed a less optimal recognition and
initial cytokine induction of C. neoformans var. grubii and var.
neoformans, which suggests that in a host with inadequate cellular
immunity this less optimal innate cytokine response leads more
easily to infection with C. neoformans var. grubii and var. neoformans
compared to C. gattii. Clinical data support this, since infections of
immunocompromised hosts with C. neoformans var grubii is far more
prevalent than infection with C. gattii [20].
A potential limitation of our study is that heat-killed instead of
live cryptococci were used. However, at the temperatures used for
heat-killing, most virulence factors (capsular polysaccharide,
lipoproteins) are retained. Moreover, in number of previous
studies, heat-killed cryptococci were used and significant inflam-
matory responses specific for capsulated and unencapsulated
cryptococci were found [21,22]. One study investigated lympho-
cyte proliferation after stimulation with live and heat-killed
cryptococci and found no difference [23]. Thus, we feel that in
this study, the use of heat-killed crytococci is justified.
Our experiments using a virulent C. gattii strain in stimulating
PBMCs that were pre-incubated with specific PRR-blocking
reagents indicate a role for TLR4 and TLR9 in recognizing
Cryptococcus and subsequently modulation of the pro-inflammatory
cytokine response. TLR4 seemed to be involved in mounting a
pro-inflammatory cytokine response. Previous studies suggest that
glucuronoxylomannan, the major capsular component [15] or
other cryptococcal cell wall elements [24] are involved in binding
to TLR4. In this study we did not design experiments in order to
identify which cell wall components are involved in the initial
cytokine response. Cytokine responses appeared to be independent
of TLR2 recognition, since blocking of this receptor had no effect
on cytokine concentrations. This contrasted with what is found in
mice by Biondo et al. who demonstrated a key role of TLR2, but
not of TLR4 [12]. Other studies, however, found no major role for
TLR2 in survival of cryptococcal infections in a murine model
[11,13].
Based on our results, a special role in Cryptococcus recognition
can be ascribed to TLR9. Unmethylated CpG-rich DNA is the
best-known ligand for this receptor. Nakamura et al. have shown
that TLR9 recognizes cryptococcal DNA [14]. We found that this
receptor mediates IL-17 production, without any effect on IL-22.
Conversely, blockade of TLR9 resulted in increased IL-1b
Table 2. Details of 11 additional C. neoformans var grubii isolates, arranged by Microsatellite Complex (MC) [29].
Number in
experiment Isolate Other specification Species Serotype MC Origin Reference/Source
I 37-07-17 Cuba 617-05 C. neoformans var grubii A MC1 Clinical Illnait Zaragozi et al., 2010
II 44-08-52 Cuba CA 1-5 C. neoformans var grubii A MC1 Environmental Illnait Zaragozi et al., 2010
III 37-07-03 Cuba 24-2b C. neoformans var grubii A MC1 Environmental Illnait Zaragozi et al., 2010
IV 36-10-01 Cuba CH-2 C. neoformans var grubii A MC2 Environmental Illnait Zaragozi et al., 2010
V 44-08-16 Cuba 569-06 C. neoformans var grubii A MC2 Clinical Illnait Zaragozi et al., 2010
VI 36-09-16 Cuba 225-99 C. neoformans var grubii A MC2 Clinical Illnait Zaragozi et al., 2010
VII 36-09-32 Cuba 227-01 C. neoformans var grubii A MC3 Clinical Illnait Zaragozi et al., 2010
VIII 36-09-57 Cuba 0119 C. neoformans var grubii A MC3 Clinical Illnait Zaragozi et al., 2010
IX 36-10-46 Cuba 30-2D C. neoformans var grubii A MC3 Environmental Illnait Zaragozi et al., 2010
X 36-10-56 Cuba 315-01 C. neoformans var grubii A MC4 Clinical Illnait Zaragozi et al., 2010
XI 36-09-53 Cuba 098 C. neoformans var grubii A MC6 Clinical Illnait Zaragozi et al., 2010
doi:10.1371/journal.pone.0055579.t002
Cryptococcus gattii Induced Cytokine Pattern
PLOS ONE | www.plosone.org 8 January 2013 | Volume 8 | Issue 1 | e55579
production in response to C. gattii. The latter effect opposes the
possible effect of TLR4. However, a specific combination of PRRs
that bind available fungal PAMPs lead to pathways that interact
with each other because of a limited set of shared adaptor molecules
and transcription factors, and converge to a tailored response [25].
Likely, TLR9 and TLR4 work together in recognizing Cryptococcus
and their signaling pathways interact downstream. Interestingly, we
did not see TLR9 dependent negative modulation of C. neoformans
var. grubii, indicating that the TLR9 dependent recognition of
Cryptococcus is species-dependent. Negative modulation of immune
responses to fungal pathogens mediated by TLR9 have been
observed in other studies [26]. As the host’s response to C. gattii relies
on an initial pro-inflammatory cytokine response more than in C.
neoformans infections, it can be speculated that susceptibility to C.
gattii is influenced by subtle TLR polymorphisms and not necessarily
by a defective adaptive immune response.
In the present study we investigated the in-vitro cytokine
production of human PBMCs incubated with 40 different heat-
killed isolates of Cryptococcus neoformans species complex. We
demonstrated that isolates of C. gattii induce higher concentrations
of the pro-inflammatory cytokines IL-1b, TNF-a and IL-6 and the
Th17/22 cytokines IL-17 and IL-22 compared to C. neoformans var
neoformans and C. neoformans var grubii. In addition, we found that
clinical C. gattii isolates induced higher amounts of IL-1beta and
IL-6 than environmental isolates. Furthermore, we demonstrated
a likely contribution of TLR4 and TLR9, but no role for TLR2, in
the host’s cytokine response to C. gattii. In conclusion, clinical C.
gattii isolates induced a more pronounced inflammatory cytokine
response compared to other Cryptococcus species and non-clinical C.
gattii that is dependent on TLR4 and TLR9 as cellular receptors.
Materials and Methods
Cryptococcal strains
Forty cryptococcal isolates from the CBS Fungal Biodiversity
Centre (Utrecht, the Netherlands) were used in this study. These
isolates were obtained from laboratory, clinical, environmental
and veterinary sources. A detailed overview of the origin, sero- and
AFLP genotype of these isolates is provided in Table 1. Twenty-
three isolates were identified as C. gattii, 5 C. neoformans var.
neoformans, 5 C. neoformans var. grubii and 7 hybrids, 3 of which were
interspecies hybrids between C. gattii and C. neoformans var.
neoformans and 4 hybrids between both C. neoformans varieties. In
addition, 11 Cuban isolates were used in separate experiments, all
identified as C. neoformans var grubii (Table 2).
Prior to the experiments, the strains were freshly grown on
Sabouraud dextrose agar plates. A suspension of each strain was
prepared in sterile phosphate buffered saline (PBS), heat-killed
overnight at 56uC and quantified by spectrophotometry at a
wavelength of 530 nm. The suspensions were checked for fungal
and bacterial growth on a Sabouraud dextrose agar plate and a
blood agar plate respectively. No growth was observed after 5
days. All strains were stored at 4uC until used.
Candida strain
Heat-killed Candida albicans ATCC MYA-3573 (UC 820), a well
described clinical isolate, suspended in sterile PBS, was used as a
positive control.
Reagents and antibodies
Bartonella LPS, a penta-acylated LPS which is an antagonist of
TLR4-dependent signaling, was obtained as previously described
[27]. An anti-TLR2 monoclonal antibody from eBioscience (San
Diego, CA, USA) was used, and an irrelevant isotype-matched
murine IgG1 k isotype (Biolegend, San Diego, CA, USA) as
control. TLR9 inhibitory oligonucleotides ODN TTAGGG (anti
TLR9) [28] and its negative control were obtained from
InvivoGen (San Diego, CA, USA).
Isolation and stimulation of PBMCs
Human peripheral blood mononuclear cells (PBMCs) were
collected from buffy coats of healthy donors after written informed
consent had been obtained. PBMCs were isolated using density
gradient centrifugation on Ficoll-Hypaque (GE Healthcare,
Uppsala, Sweden). The cells from the interphase were aspirated
and washed three times in sterile PBS and resuspended in culture
medium RPMI 1640 Dutch modification (Sigma-Alderich, St
Louis, MO, USA) supplemented with 1% L-glutamine, 1%
pyruvate and 1% gentamicin. Cells were counted in a Coulter
Counter ZH (Beckman Coulter, Fullerton, CA, USA), and adjusted
to 56106 cells/ml. Thereafter, they were incubated in a round-
bottom 96-wells plate (volume 200 ml/well) at 37uC and 5% CO2
with either one of the heat-killed cryptococcal strains (final
concentration of 107/ml), or heat-killed C. albicans (final concen-
tration of 105/mL, which is known to induce substantial amounts
of cytokines) or culture medium alone. After 24 hours or 7 days (in
the presence of 10% human pool serum) supernatants were
collected and stored at 220uC until being assayed.
In a subsequent experiment, PBMCs were preincubated for one
hour with inhibitory ligand for TLR4 (Bartonella quintana LPS
(200 ng/ml) or culture medium as control, anti-TLR2 or control
antibody (10 mg/ml), TLR9 inhibitory oligonucleotides and its
negative control (25 mg/ml). After preincubation, C. gattii B5742,
isolate 27 in the previous experiment, or specific TLR ligands were
added, such as Pam3cys or E.coli LPS (10 mg/ml and 10 ng/ml
respectively] and PBMCs were incubated as described.
Cytokine assays
Tumor necrosis factor-a (TNF-a), Interleukin-1b (IL-1b), IL-6
and IL-1 receptor antagonist (IL-1Ra) concentrations were deter-
mined from the culture supernatant after 24 hours of incubation
using commercially available ELISA kits (TNF-a, IL-1b and IL-
1Ra: R&D systems, Minneapolis, MN, USA. IL-6: Sanquin,Am-
sterdam, the Netherlands) according to the manufacturer’s instruc-
tions. T-cell derived cytokines IL-17 and IL-22 concentrations were
determined in the supernatant after 7 days of incubation using
ELISA kits (R&D systems). Lower detection limits were 78 pg/ml,
39 pg/ml, 15 pg/ml, 200 pg/ml, 40 pg/ml and 78 pg/ml for
TNF-a, IL-1b, IL-6, IL-1Ra, IL-17 and IL-22 respectively.
Ethics statement
Written informed consent of healthy donors was provided. The
study was approved by the Medical Ethical Committee Arnhem-
Nijmegen in the Netherlands.
Statistical analysis
Results from at least three different experiments with a range of
5–7 donors were pooled and analyzed using GraphPad Prism 5
software (GraphPad, San Diego, CA). Data are given as mean 6
SE. The Mann-Whitney U-test for unpaired, nonparametrical
data was used to compare differences in cytokine production
between two groups. The Kruskal-Wallis test with Dunn’s multiple
comparison test was used when more than two groups were
compared. The Wilcoxon matched-pairs signed rank test was used
to analyze differences in cytokine production between inhibitors
and their controls in the inhibition experiments. The level of
significance was set at p,0.05.
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Supporting Information
Figure S1 IL-1b induction by Pam3cys and E. coli LPS
after blocking of TLR2 and TLR4 respectively. IL-1b
production by human PBMCs is shown (A) induced by pam3cys
[10 mg/ml] after preincubated for one hour with anti-TLR2 or
control antibody [10 mg/ml] and (B) by E. coli LPS [10 ng/ml]
after preincubation for one hour with TLR4 antagonist Bartonella
quintana LPS [200 ng/ml] or culture medium. Mean values
(n = 10) 6 SE of five independent experiments are presented.
(TIF)
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